20052019
If you made any changes in Pure these will be visible here soon.

Research Output 2005 2019

2014

Biobanking of CSF: International standardization to optimize biomarker development

Teunissen, C. E., Tumani, H., Engelborghs, S. & Mollenhauer, B., 2014, In : Clinical Biochemistry. 47, 4-5, p. 288-292

Research output: Contribution to journalArticleAcademicpeer-review

BRI2-BRICHOS is increased in human amyloid plaques in early stages of Alzheimer's disease

del Campo, M., Hoozemans, J. J. M., Dekkers, L. L., Rozemuller, A. J. M., Korth, C., Muller-Schiffmann, A., Scheltens, P., Blankenstein, M. A., Jimenez, C. R., Veerhuis, R. & Teunissen, C. E., 2014, In : Neurobiology of Aging. 35, 7, p. 1596-1604

Research output: Contribution to journalArticleAcademicpeer-review

Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables

Vuletic, S., Kennedy, H., Albers, J. J., Killestein, J., Vrenken, H., Lütjohann, D. & Teunissen, C. E., 2014, In : Multiple Sclerosis and Related Disorders. 3, 4, p. 533-541

Research output: Contribution to journalArticleAcademicpeer-review

Cerebrospinal fluid levels of Alzheimer's disease biomarkers in middle-aged patients with type 1 diabetes

Ouwens, D. M., van Duinkerken, E., Schoonenboom, S. N. M., de Wiza, D. H., Klein, M., van Golen, L. W., Pouwels, P. J. W., Barkhof, F., Moll, A. C., Snoek, F. J., Teunissen, C. E., Scheltens, P. & Diamant, M., 2014, In : Diabetologia. 57, 10, p. 2208-2214

Research output: Contribution to journalArticleAcademicpeer-review

Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis

Khalil, M., Riedlbauer, B., Langkammer, C., Enzinger, C., Ropele, S., Stojakovic, T., Scharnagl, H., Culea, V., Petzold, A. F. S., Teunissen, C. E., Archelos, J. J., Fuchs, S. & Fazekas, F., 2014, In : Multiple Sclerosis. 20, 12, p. 1569-1577

Research output: Contribution to journalArticleAcademicpeer-review

Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders

Gnanapavan, S., Hegen, H., Khalil, M., Hemmer, B., Franciotta, D., Hughes, S., Hintzen, R., Jeromin, A., Havrdova, E., Tumani, H., Bertolotto, A., Comabella, M., Frederiksen, J., varez-Cermeno, J. C., Villar, L., Galimberti, D., Myhr, K. M., Dujmovic, I., Fazekas, F., Ionete, C. & 6 othersMenge, T., Kuhle, J., Keir, G., Deisenhammer, F., Teunissen, C. E. & Giovannoni, G., 2014, In : Neurology. 83, 13, p. 1210-1216

Research output: Contribution to journalArticleAcademicpeer-review

N-Acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis

Trentini, A., Comabella, M., Tintore, M., Simmelink, M. J. A., Killestein, J., Roos, B., Rovira, A., Korth, C., Ottis, P., Blankenstein, M. A., Montalban, X., Bellini, T. & Teunissen, C. E., 2014, In : Journal of Neurology. 261, 12, p. 2338-2343

Research output: Contribution to journalArticleAcademicpeer-review

Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis

van de Kraats, C., Killestein, J., Popescu, V., rijkers, E., Vrenken, H., Lutjohann, D., Barkhof, F., Polman, C. H. & Teunissen, C. E., 2014, In : Multiple Sclerosis. 20, 4, p. 412-417

Research output: Contribution to journalArticleAcademicpeer-review

Proteomic analysis of cerebrospinal fluid extracellular vesicles: A comprehensive dataset

Chiasserini, D., van Weering, J. R. T., Piersma, S. R., Pham, T. V., Malekzadeh, A., Teunissen, C. E., de Wit, H. & Jimenez, C. R., 2014, In : Journal of Proteomics. 106, p. 191-204

Research output: Contribution to journalArticleAcademicpeer-review

Role of BRI2 in Dementia

del Campo, M. & Teunissen, C. E., 2014, In : Journal of Alzheimer's Disease. 40, 3, p. 481-494

Research output: Contribution to journalArticleAcademicpeer-review

SUCLG2 identified as both a determinator of CSF Abeta1-42 levels and an attenuator of cognitive decline in Alzheimer's disease

Ramirez, A., van der Flier, W. M., Herold, C., Ramonet, D., Heilmann, S., Lewczuk, P., Popp, J., Lacour, A., Drichel, D., Louwersheimer, E., Kummer, M. P., Cruchaga, C., Hoffmann, P., Teunissen, C. E., Holstege, H., Kornhuber, J., Peters, O., Naj, A. C., Chouraki, V., Bellenguez, C. & 17 othersGerrish, A., Heun, R., Frolich, L., Hull, M., Buscemi, L., Herms, S., Kolsch, H., Scheltens, P., Breteler, M. M., Ruther, E., Wiltfang, J., Goate, A., Jessen, F., Maier, W., Heneka, M. T., Becker, T. & Nothen, M. M., 2014, In : Human Molecular Genetics. 23, 24, p. 6644-6658

Research output: Contribution to journalArticleAcademicpeer-review

Sulfatide-mediated control of extracellular matrix-dependent oligodendrocyte maturation

Baron, W., Bijlard, M., Nomden, A., de Jonge, J. C., Teunissen, C. E. & Hoekstra, D., 2014, In : GLIA. 62, 6, p. 927-942

Research output: Contribution to journalArticleAcademicpeer-review

The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease

Jochemsen, H. M., Teunissen, C. E., Ashby, E. L., van der Flier, W. M., Jones, R. E., Geerlings, M. I., Scheltens, P., Kehoe, P. G. & Muller, M., 2014, In : Alzheimer's Research & Therapy. 6, 3, p. 27 27.

Research output: Contribution to journalArticleAcademicpeer-review

The cerebrospinal fluid "Alzheimer profile": Easily said, but what does it mean?

Duits, F. H., Teunissen, C. E., Bouwman, F. H., Visser, P. J., Mattsson, N., Zetterberg, H., Blennow, K., Hansson, O., Minthon, L., Andreasen, N., Marcusson, J., Wallin, A., Rikkert, M. O., Tsolaki, M., Parnetti, L., Herukka, S. K., Hampel, H., de Leon, M. J., Schroder, J., Aarsland, D. & 3 othersBlankenstein, M. A., Scheltens, P. & van der Flier, W. M., 2014, In : Alzheimers & Dementia. 10, 6, p. 713-723

Research output: Contribution to journalArticleAcademicpeer-review

The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

Molinuevo, J. L., Blennow, K., Dubois, B., Engelborghs, S., Lewczuk, P., Perret-Liaudet, A., Teunissen, C. E. & Parnetti, L., 2014, In : Alzheimers & Dementia. 10, 6, p. 808-817

Research output: Contribution to journalArticleAcademicpeer-review

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results

Aalten, P., Ramakers, I. H. G. B., Biessels, G. J., de Deyn, P. P., Koek, H. L., Olde Rikkert, M. G. M., Oleksik, A. M., Richard, E., Smits, L. L., van Swieten, J. C., Teune, L. K., van der Lugt, A., Barkhof, F., Teunissen, C. E., Rozendaal, N., Verhey, F. R. J. & van der Flier, W. M., 2014, In : BMC Neurology. 14, 254.

Research output: Contribution to journalArticleAcademicpeer-review

The road less traveled: CSF biomarkers for Alzheimer's disease: Predicting earliest cognitive decline and exploring microRNA as a novel biomarker source

van Harten, A. C., 2014

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

Variability of CSF Alzheimer's Disease Biomarkers: Implications for Clinical Practice

Vos, S. J. B., Visser, P. J., Verhey, F., Aalten, P., Knol, D., Ramakers, I., Scheltens, P., Rikkert, M. G. M. O., Verbeek, M. M. & Teunissen, C. E., 2014, In : PLoS ONE. 9, 6, p. e100784 e100784.

Research output: Contribution to journalArticleAcademicpeer-review

2013

Alzheimer Disease Biomarker Testing in Cerebrospinal Fluid: A Method to Harmonize Assay Platforms in the Absence of an Absolute Reference Standard

Vanderstichele, H. M., Shaw, L., Vandijck, M., Jeromin, A., Zetterberg, H., Blennow, K., Teunissen, C. & Engelborghs, S., 2013, In : Clinical Chemistry. 59, 4, p. 710-712

Research output: Contribution to journalArticleAcademicpeer-review

A prediction model to calculate probability of Alzheimer's disease using cerebrospinal fluid biomarkers

Spies, P. E., Claassen, J. A. H. R., Peer, P. G. M., Blankenstein, M. A., Teunissen, C. E., Scheltens, P., van der Flier, W. M., Rikkert, M. G. M. O. & Verbeek, M. M., 2013, In : Alzheimers & Dementia. 9, 3, p. 262-268

Research output: Contribution to journalArticleAcademicpeer-review

Biomarker Report from the Phase II Lamotrigine Trial in Secondary Progressive MS - Neurofilament as a Surrogate of Disease Progression

Gnanapavan, S., Grant, D., Morant, S., Furby, J., Hayton, T., Teunissen, C. E., Leoni, V., Marta, M., Brenner, R., Palace, J., Miller, D. H., Kapoor, R. & Giovannoni, G., 2013, In : PLoS ONE. 8, 8, p. e70019 e70019.

Research output: Contribution to journalArticleAcademicpeer-review

Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis

Teunissen, C., Menge, T., Altintas, A., Alvarez-Cermeno, J. C., Bertolotto, A., Berven, F. S., Brundin, L., Comabella, M., Degn, M., Deisenhammer, F., Fazekas, F., Franciotta, D., Frederiksen, J. L., Galimberti, D., Gnanapavan, S., Hegen, H., Hemmer, B., Hintzen, R., Hughes, S., Iacobaeus, E. & 9 othersKroksveen, A. C., Kuhle, J., Richert, J., Tumani, H., Villar, L. M., Drulovic, J., Dujmovic, I., Khalil, M. & Bartos, A., 2013, In : Multiple Sclerosis. 19, 13, p. 1802-1809

Research output: Contribution to journalArticleAcademicpeer-review

CSF biomarker variability in the Alzheimer's Association quality control program

Mattsson, N., Andreasson, U., Persson, S., Carrillo, M. C., Collins, S., Chalbot, S., Cutler, N., Dufour-Rainfray, D., Fagan, A. M., Heegaard, N. H. H., Hsiung, G. Y. R., Hyman, B., Iqbal, K., Lachno, D. R., Lleo, A., Lewczuk, P., Molinuevo, J. L., Parchi, P., Regeniter, A., Rissman, R. & 12 othersRosenmann, H., Sancesario, G., Schroder, J., Shaw, L. M., Teunissen, C. E., Trojanowski, J. Q., Vanderstichele, H., Vandijck, M., Verbeek, M. M., Zetterberg, H., Blennow, K. & Kaser, S. A., 2013, In : Alzheimers & Dementia. 9, 3, p. 251-261

Research output: Contribution to journalArticleAcademicpeer-review

CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome

Khalil, M. B., Enzinger, C., Langkammer, C., Ropele, S., Mader, A., Trentini, A., Vane, M. L. G., Wallner-Blazek, M., Bachmaier, G., Archelos, J. J., Simmelink, M. J. A., Blankenstein, M. A., Fuchs, S., Fazekas, F. & Teunissen, C. E., 2013, In : Multiple Sclerosis. 19, 4, p. 436-442

Research output: Contribution to journalArticleAcademicpeer-review

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM

Kroksveen, A. C., Aasebo, E., Vethe, H., van Pesch, V., Franciotta, D., Teunissen, C. E., Ulvik, R. J., Vedeler, C., Myhr, K. M., Barsnes, H. & Berven, F. S., 2013, In : Journal of Proteomics. 78, p. 312-325

Research output: Contribution to journalArticleAcademicpeer-review

HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter

Melief, J., de Wit, S. J., van Eden, C. G., Teunissen, C., Hamann, J., Uitdehaag, B. M. J., Swaab, D. & Huitinga, I., 2013, In : Acta Neuropathologica. 126, 2, p. 237-249

Research output: Contribution to journalArticleAcademicpeer-review

31 Downloads (Pure)

Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status

Vogel, D. Y. S., Vereyken, E. J. F., Glim, J. E., Heijnen, D. A. M., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J. & Dijkstra, C. D., 2013, In : Journal of Neuroinflammation. 10, p. 35 35.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File

Preclinical AD predicts decline in memory and executive functions in subjective complaints

van Harten, A. C., Smits, L. L., Teunissen, C. E., Visser, P. J., Koene, T., Blankenstein, M. A., Scheltens, P. & van der Flier, W. M., 2013, In : Neurology. 81, 16, p. 1409-1416

Research output: Contribution to journalArticleAcademicpeer-review

Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease

Prestia, A., Caroli, A., van der Flier, W. M., Ossenkoppele, R., van Berckel, B. N. M., Barkhof, F., Teunissen, C. E., Wall, A. E., Carter, S. F., Scholl, M., Choo, I. H., Nordberg, A., Scheltens, P. & Frisoni, G. B., 2013, In : Neurology. 80, 11, p. 1048-1056

Research output: Contribution to journalArticleAcademicpeer-review

Recent progress in omics-driven analysis of MS to unravel pathological mechanisms

Malekzadeh, A. & Teunissen, C., 2013, In : Expert Review of Neurotherapeutics. 13, 9, p. 1001-1016

Research output: Contribution to journalArticleAcademicpeer-review

The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme

Beckerman, H., Blikman, L. J. M., Heine, M., Malekzadeh, A., Teunissen, C. E., Bussmann, J. B. J., Kwakkel, G., van Meeteren, J. & de Groot, V., 2013, In : Trials. 14, p. 250 250.

Research output: Contribution to journalArticleAcademicpeer-review

37 Downloads (Pure)

Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort.

Schoonenboom, N. S. M., Reesink, F. E., Verwey, N. A., Kester, M. I., Teunissen, C. E., van de Ven, P. M., Pijnenburg, Y. A. L., Blankenstein, M. A., Rozemuller, J. M., Scheltens, P. & van der Flier, W. M., 2012, In : Neurology. 78, 1, p. 47-54

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File

Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases

Malekzadeh, A., de Groot, V., Beckerman, H., van Oosten, B. W., Blankenstein, M. A. & Teunissen, C. E., 2012, In : Methods. 56, 4, p. 508-513

Research output: Contribution to journalArticleAcademicpeer-review

43 Downloads (Pure)

Clinical significance of MRI and body fluid markers for disease progression in multiple sclerosis

Khalil, M. B., 2012

Research output: ThesisResearch VU University Amsterdam, graduation VU University AmsterdamAcademic

File

Disease specific cerebrospinal fluid investigations

Deisenhammer, F., Egg, R., Giovannoni, G., Hemmer, B., Petzold, A. F. S., Sellebjerg, F., Teunissen, C. E. & Tumani, H., 2012, European Handbook of Neurological Management, Vol. 2. Oxford, UK: Wiley-Blackwell Publishers, p. 175-197

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Early Onset Alzheimer's Disease is Associated with a Distinct Neuropsychological Profile

Smits, L. L., Pijnenburg, Y. A. L., Koedam, E. L. G. E., van der Vlies, A. E., Reuling, I. E. W., Koene, T., Teunissen, C. E., Scheltens, P. & van der Flier, W. M., 2012, In : Journal of Alzheimer's Disease. 30, 1, p. 101-108

Research output: Contribution to journalArticleAcademicpeer-review

Effectiviteit van aerobe training, cognitieve gedragstherapie en energiemanagement bij MS-gerelateerde vermoeidheid. TREFAMS-ACE studie

van Meeteren, J., Blikman, L. J. M., Heine, M., Malekzadeh, A., Teunissen, C. E., Bussmann, J. B. J., Kwakkel, G., Beckerman, H. & de Groot, V., 2012, In : Nederlands Tijdschrift voor Revalidatiegeneeskunde. 2012, 6, p. 301-306

Research output: Contribution to journalArticleProfessional

Increased plasma 8,12-iso-iPF2alpha-VI levels in relapsing multiple sclerosis patients are not predictive of disease progression

Teunissen, C. E., Sombekke, M. H., van Winsen, L., Killestein, J., Barkhof, F., Polman, C. H., Dijkstra, C. D., Blankenstein, M. A. & Pratico, D., 2012, In : Multiple Sclerosis. 18, 8, p. 1092-1098

Research output: Contribution to journalArticleAcademicpeer-review

27 Downloads (Pure)

Injury markers predict time to dementia in subjects with MCI and amyloid pathology

van Rossum, I. A., Vos, S. J. B., Burns, L., Knol, D. L., Scheltens, P., Soininen, H., Wahlund, L. O., Hampel, H., Tsolaki, M., Minthon, L., L'Italien, G., van der Flier, W. M., Teunissen, C. E., Blennow, K., Barkhof, F., Rueckert, D., Wolz, R., Verhey, F. & Visser, P. J., 2012, In : Neurology. 79, 17, p. 1809-1816

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
File